APA

Hiddemann W., Martin W. R., Sauerland C. M., Heinecke A. & Büchner T. (19900425). Definition of refractoriness against conventional chemotherapy in acute myeloid leukemia: a proposal based on the results of retreatment by thioguanine, cytosine arabinoside, and daunorubicin (TAD 9) in 150 patients with relapse after standardized first line therapy. : Leukemia.

Chicago

Hiddemann W, Martin W R, Sauerland C M, Heinecke A and Büchner T. 19900425. Definition of refractoriness against conventional chemotherapy in acute myeloid leukemia: a proposal based on the results of retreatment by thioguanine, cytosine arabinoside, and daunorubicin (TAD 9) in 150 patients with relapse after standardized first line therapy. : Leukemia.

Harvard

Hiddemann W., Martin W. R., Sauerland C. M., Heinecke A. and Büchner T. (19900425). Definition of refractoriness against conventional chemotherapy in acute myeloid leukemia: a proposal based on the results of retreatment by thioguanine, cytosine arabinoside, and daunorubicin (TAD 9) in 150 patients with relapse after standardized first line therapy. : Leukemia.

MLA

Hiddemann W, Martin W R, Sauerland C M, Heinecke A and Büchner T. Definition of refractoriness against conventional chemotherapy in acute myeloid leukemia: a proposal based on the results of retreatment by thioguanine, cytosine arabinoside, and daunorubicin (TAD 9) in 150 patients with relapse after standardized first line therapy. : Leukemia. 19900425.